Researching sources and building the cash-grab verdict…
The first visit can take longer because the report checks current sources before publishing a score.
Researching sources and building the cash-grab verdict…
The first visit can take longer because the report checks current sources before publishing a score.

2019
The sourced concerns are substantially offset by delivered value.
Commercial extraction prioritized over meaningful consumer or creative value. Profit, popularity, adaptations, sequels, remakes, high budgets, and normal marketing do not count by themselves.
Dr. STONE is a 2019 anime adaptation of the manga by Riichiro Inagaki and Boichi that aired July 5, 2019 to December 13, 2019, produced by TMS Entertainment and simulcast on Crunchyroll. I found no credible trade reporting that the TV series was structured as a predatory monetization vehicle. Instead factual sources and reviews document a standard broadcast and streaming release, named production staff, multiple full seasons adapting major manga arcs, and generally positive critical reaction to its concept, writing, and production values.
| Direction | Factor | Evidence | Impact |
|---|---|---|---|
| Against | Official production and staff | The TV series lists TMS Entertainment as the animation studio with named director, writers, and composers, indicating a standard studio production pipeline.[2][1] | -16 |
| Against | Substantive multi-season adaptation | The anime has been produced across multiple seasons and adapts distinct manga arcs, indicating substantive content rather than a single quick cash exploitation.[1][5] | -15 |
| For | No reported predatory monetization | I found no trade or mainstream reporting alleging predatory monetization practices tied to the Dr. STONE TV anime adaptation.[3][4] | +8 |
| Against | Standard simulcast and TV distribution | The series was simulcast on Crunchyroll at premiere and later received English broadcast windows, consistent with normal anime distribution rather than pay-to-win or microtransaction-first release.[3][4] | -8 |
| Against | Independent reviews praise craft | Independent reviews and aggregator pages highlight the series' premise, science-forward writing, music, and generally positive reception rather than complaints about low-effort reuse.[7][6] | -7 |
| For | No reported price versus value complaints | I did not find industry coverage or consumer reporting about deceptive home media pricing, hidden fees, or a clear price/value mismatch for the TV series releases.[2][1] | +6 |
| For | No evidence of rushed or deceptive release | Broadcast dates, episode lists, and press rollout are consistent and continuous with no cited rushed premiere or deceptive release practices in trade reports.[8][3] | +5 |
Confidence: High · Major trade, official studio pages, and independent review outlets were checked and consistently show standard production and distribution without credible reporting of predatory monetization, though fringe fan complaints appear on forums. · Researched 2026-08-09
Agree or disagree with the AI's cash-grab read. One vote per browser on this title.
Loading community verdict…